| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Head of North America
1 company
Lee Jennifer Kayden is an EVP, Head of North America at RYTM. Recent filings cover 0 purchases and 36 sales.
Our model assigns Lee Jennifer Kayden a below-average insider score of 35/100, based on 23 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -68.4%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sale+OE10b5-1 | 75,834 | $117.38 | $8,901,531.42 | - | - | - | |
| Feb 19, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sale+OE10b5-1 | 2,035 | $57.22 | $116,442.70 | -25.8% | +10.1% | +77.9% | |
| Feb 13, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sell10b5-1 | 3,020 | $57.03 | $172,238.05 | -55.8% | -0.5% | +70.4% | |
| Feb 11, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sale+OE10b5-1 | 5,216 | $58.64 | $305,845.83 | -49.1% | +2.4% | +71.0% | |
| Feb 5, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sell10b5-1 | 3,066 | $60.55 | $185,640.20 | -75.9% | +2.8% | +70.2% | |
| Feb 4, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sale+OE | 1,447 | $59.43 | $85,995.21 | -26.4% | +7.4% | +80.1% | |
| Nov 11, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sale+OE10b5-1 | 66,861 | $66.33 | $4,434,882.42 | -98.6% | -10.8% | +52.3% | |
| Mar 20, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sell | 18,235 | $38.77 | $707,004.96 | -72.7% | +4.3% | +36.7% | |
| Mar 19, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sell | 15,515 | $39.22 | $608,498.30 | -38.2% | +5.2% | +41.1% | |
| Feb 13, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sale+OE | 1,638 | $50.80 | $83,207.19 | -19.3% | -17.8% | +17.9% |